nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Sorafenib—thyroid cancer	0.158	0.331	CbGbCtD
Metronidazole—CYP2C9—Sorafenib—thyroid cancer	0.11	0.231	CbGbCtD
Metronidazole—CYP3A4—Vandetanib—thyroid cancer	0.106	0.223	CbGbCtD
Metronidazole—CYP3A4—Sorafenib—thyroid cancer	0.0639	0.134	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—thyroid cancer	0.0388	0.0814	CbGbCtD
Metronidazole—Eructation—Doxorubicin—thyroid cancer	0.000956	0.00183	CcSEcCtD
Metronidazole—Bladder pain—Epirubicin—thyroid cancer	0.000951	0.00182	CcSEcCtD
Metronidazole—Neoplasm—Epirubicin—thyroid cancer	0.000951	0.00182	CcSEcCtD
Metronidazole—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00095	0.00182	CcSEcCtD
Metronidazole—Rash—Vandetanib—thyroid cancer	0.000949	0.00181	CcSEcCtD
Metronidazole—Dermatitis—Vandetanib—thyroid cancer	0.000948	0.00181	CcSEcCtD
Metronidazole—Influenza like illness—Doxorubicin—thyroid cancer	0.000945	0.0018	CcSEcCtD
Metronidazole—Headache—Vandetanib—thyroid cancer	0.000943	0.0018	CcSEcCtD
Metronidazole—Cystitis—Doxorubicin—thyroid cancer	0.00094	0.00179	CcSEcCtD
Metronidazole—Candida infection—Doxorubicin—thyroid cancer	0.000929	0.00177	CcSEcCtD
Metronidazole—Skin exfoliation—Doxorubicin—thyroid cancer	0.000929	0.00177	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000925	0.00177	CcSEcCtD
Metronidazole—Vaginal infection—Doxorubicin—thyroid cancer	0.000919	0.00175	CcSEcCtD
Metronidazole—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000914	0.00174	CcSEcCtD
Metronidazole—Neuropathy—Doxorubicin—thyroid cancer	0.000914	0.00174	CcSEcCtD
Metronidazole—Nausea—Vandetanib—thyroid cancer	0.000894	0.00171	CcSEcCtD
Metronidazole—Dyspepsia—Sorafenib—thyroid cancer	0.000894	0.00171	CcSEcCtD
Metronidazole—Decreased appetite—Sorafenib—thyroid cancer	0.000882	0.00169	CcSEcCtD
Metronidazole—Thrombophlebitis—Epirubicin—thyroid cancer	0.000882	0.00168	CcSEcCtD
Metronidazole—Neoplasm—Doxorubicin—thyroid cancer	0.00088	0.00168	CcSEcCtD
Metronidazole—Bladder pain—Doxorubicin—thyroid cancer	0.00088	0.00168	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000876	0.00167	CcSEcCtD
Metronidazole—Fatigue—Sorafenib—thyroid cancer	0.000875	0.00167	CcSEcCtD
Metronidazole—Photosensitivity—Epirubicin—thyroid cancer	0.000869	0.00166	CcSEcCtD
Metronidazole—Pain—Sorafenib—thyroid cancer	0.000868	0.00166	CcSEcCtD
Metronidazole—Constipation—Sorafenib—thyroid cancer	0.000868	0.00166	CcSEcCtD
Metronidazole—Hepatic failure—Epirubicin—thyroid cancer	0.000849	0.00162	CcSEcCtD
Metronidazole—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00083	0.00159	CcSEcCtD
Metronidazole—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000816	0.00156	CcSEcCtD
Metronidazole—Urticaria—Sorafenib—thyroid cancer	0.000806	0.00154	CcSEcCtD
Metronidazole—Photosensitivity—Doxorubicin—thyroid cancer	0.000804	0.00154	CcSEcCtD
Metronidazole—Abdominal pain—Sorafenib—thyroid cancer	0.000803	0.00153	CcSEcCtD
Metronidazole—Body temperature increased—Sorafenib—thyroid cancer	0.000803	0.00153	CcSEcCtD
Metronidazole—Dermatitis bullous—Epirubicin—thyroid cancer	0.000799	0.00153	CcSEcCtD
Metronidazole—Hepatic failure—Doxorubicin—thyroid cancer	0.000786	0.0015	CcSEcCtD
Metronidazole—Osteoarthritis—Epirubicin—thyroid cancer	0.000763	0.00146	CcSEcCtD
Metronidazole—Diplopia—Epirubicin—thyroid cancer	0.000763	0.00146	CcSEcCtD
Metronidazole—Hypersensitivity—Sorafenib—thyroid cancer	0.000748	0.00143	CcSEcCtD
Metronidazole—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000739	0.00141	CcSEcCtD
Metronidazole—Asthenia—Sorafenib—thyroid cancer	0.000728	0.00139	CcSEcCtD
Metronidazole—Pruritus—Sorafenib—thyroid cancer	0.000718	0.00137	CcSEcCtD
Metronidazole—Ataxia—Epirubicin—thyroid cancer	0.000718	0.00137	CcSEcCtD
Metronidazole—Diplopia—Doxorubicin—thyroid cancer	0.000706	0.00135	CcSEcCtD
Metronidazole—Osteoarthritis—Doxorubicin—thyroid cancer	0.000706	0.00135	CcSEcCtD
Metronidazole—Liver function test abnormal—Epirubicin—thyroid cancer	0.000705	0.00135	CcSEcCtD
Metronidazole—Dry skin—Epirubicin—thyroid cancer	0.0007	0.00134	CcSEcCtD
Metronidazole—Abdominal pain upper—Epirubicin—thyroid cancer	0.000697	0.00133	CcSEcCtD
Metronidazole—Diarrhoea—Sorafenib—thyroid cancer	0.000695	0.00133	CcSEcCtD
Metronidazole—Breast disorder—Epirubicin—thyroid cancer	0.00069	0.00132	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000687	0.00131	CcSEcCtD
Metronidazole—Nasopharyngitis—Epirubicin—thyroid cancer	0.000683	0.0013	CcSEcCtD
Metronidazole—Dizziness—Sorafenib—thyroid cancer	0.000671	0.00128	CcSEcCtD
Metronidazole—Abdominal distension—Epirubicin—thyroid cancer	0.000664	0.00127	CcSEcCtD
Metronidazole—Ataxia—Doxorubicin—thyroid cancer	0.000664	0.00127	CcSEcCtD
Metronidazole—Asthma—Epirubicin—thyroid cancer	0.00066	0.00126	CcSEcCtD
Metronidazole—Influenza—Epirubicin—thyroid cancer	0.00066	0.00126	CcSEcCtD
Metronidazole—Eosinophilia—Epirubicin—thyroid cancer	0.000653	0.00125	CcSEcCtD
Metronidazole—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000652	0.00125	CcSEcCtD
Metronidazole—Dry skin—Doxorubicin—thyroid cancer	0.000647	0.00124	CcSEcCtD
Metronidazole—Pancreatitis—Epirubicin—thyroid cancer	0.000647	0.00124	CcSEcCtD
Metronidazole—Vomiting—Sorafenib—thyroid cancer	0.000645	0.00123	CcSEcCtD
Metronidazole—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000645	0.00123	CcSEcCtD
Metronidazole—Rash—Sorafenib—thyroid cancer	0.00064	0.00122	CcSEcCtD
Metronidazole—Dermatitis—Sorafenib—thyroid cancer	0.000639	0.00122	CcSEcCtD
Metronidazole—Breast disorder—Doxorubicin—thyroid cancer	0.000638	0.00122	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000636	0.00121	CcSEcCtD
Metronidazole—Headache—Sorafenib—thyroid cancer	0.000636	0.00121	CcSEcCtD
Metronidazole—Bronchitis—Epirubicin—thyroid cancer	0.000634	0.00121	CcSEcCtD
Metronidazole—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000632	0.00121	CcSEcCtD
Metronidazole—Pancytopenia—Epirubicin—thyroid cancer	0.000627	0.0012	CcSEcCtD
Metronidazole—Neutropenia—Epirubicin—thyroid cancer	0.000617	0.00118	CcSEcCtD
Metronidazole—Dysuria—Epirubicin—thyroid cancer	0.000617	0.00118	CcSEcCtD
Metronidazole—Abdominal distension—Doxorubicin—thyroid cancer	0.000615	0.00117	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000613	0.00117	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—thyroid cancer	0.00061	0.00117	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—thyroid cancer	0.00061	0.00117	CcSEcCtD
Metronidazole—Pollakiuria—Epirubicin—thyroid cancer	0.000609	0.00116	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—thyroid cancer	0.000604	0.00115	CcSEcCtD
Metronidazole—Nausea—Sorafenib—thyroid cancer	0.000603	0.00115	CcSEcCtD
Metronidazole—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000602	0.00115	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—thyroid cancer	0.000598	0.00114	CcSEcCtD
Metronidazole—Infestation NOS—Epirubicin—thyroid cancer	0.000588	0.00112	CcSEcCtD
Metronidazole—Infestation—Epirubicin—thyroid cancer	0.000588	0.00112	CcSEcCtD
Metronidazole—Drowsiness—Epirubicin—thyroid cancer	0.000588	0.00112	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—thyroid cancer	0.000587	0.00112	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000583	0.00111	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—thyroid cancer	0.00058	0.00111	CcSEcCtD
Metronidazole—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000577	0.0011	CcSEcCtD
Metronidazole—Jaundice—Epirubicin—thyroid cancer	0.000573	0.0011	CcSEcCtD
Metronidazole—Stomatitis—Epirubicin—thyroid cancer	0.000573	0.0011	CcSEcCtD
Metronidazole—Conjunctivitis—Epirubicin—thyroid cancer	0.000572	0.00109	CcSEcCtD
Metronidazole—Urinary tract infection—Epirubicin—thyroid cancer	0.000572	0.00109	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—thyroid cancer	0.000571	0.00109	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—thyroid cancer	0.000571	0.00109	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000567	0.00108	CcSEcCtD
Metronidazole—Sweating—Epirubicin—thyroid cancer	0.000564	0.00108	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—thyroid cancer	0.000564	0.00108	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000557	0.00106	CcSEcCtD
Metronidazole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000556	0.00106	CcSEcCtD
Metronidazole—Sinusitis—Epirubicin—thyroid cancer	0.000552	0.00105	CcSEcCtD
Metronidazole—Agranulocytosis—Epirubicin—thyroid cancer	0.000549	0.00105	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—thyroid cancer	0.000544	0.00104	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—thyroid cancer	0.000544	0.00104	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—thyroid cancer	0.000544	0.00104	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00054	0.00103	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000534	0.00102	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—thyroid cancer	0.000531	0.00101	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—thyroid cancer	0.000531	0.00101	CcSEcCtD
Metronidazole—Rhinitis—Epirubicin—thyroid cancer	0.000529	0.00101	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—thyroid cancer	0.000529	0.00101	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—thyroid cancer	0.000529	0.00101	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—thyroid cancer	0.000528	0.00101	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—thyroid cancer	0.000525	0.001	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—thyroid cancer	0.000524	0.001	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—thyroid cancer	0.000522	0.000997	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—thyroid cancer	0.000519	0.000991	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000515	0.000983	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—thyroid cancer	0.000511	0.000975	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—thyroid cancer	0.000509	0.000972	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—thyroid cancer	0.000508	0.00097	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—thyroid cancer	0.000499	0.000954	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—thyroid cancer	0.000493	0.000943	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—thyroid cancer	0.000492	0.00094	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—thyroid cancer	0.00049	0.000936	CcSEcCtD
Metronidazole—Flushing—Epirubicin—thyroid cancer	0.00049	0.000936	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—thyroid cancer	0.00049	0.000936	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—thyroid cancer	0.000489	0.000933	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000486	0.000929	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—thyroid cancer	0.000485	0.000926	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00048	0.000917	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—thyroid cancer	0.000479	0.000915	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—thyroid cancer	0.000477	0.000911	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—thyroid cancer	0.000476	0.000909	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—thyroid cancer	0.000471	0.000899	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—thyroid cancer	0.000463	0.000884	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—thyroid cancer	0.000462	0.000882	CcSEcCtD
Metronidazole—Erythema—Epirubicin—thyroid cancer	0.00046	0.000878	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—thyroid cancer	0.000457	0.000872	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—thyroid cancer	0.000456	0.00087	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—thyroid cancer	0.000453	0.000866	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—thyroid cancer	0.000453	0.000866	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—thyroid cancer	0.000453	0.000865	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—thyroid cancer	0.00045	0.00086	CcSEcCtD
Metronidazole—Back pain—Epirubicin—thyroid cancer	0.000445	0.000849	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—thyroid cancer	0.000443	0.000847	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—thyroid cancer	0.000442	0.000844	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—thyroid cancer	0.000441	0.000843	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00044	0.000841	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—thyroid cancer	0.000433	0.000827	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—thyroid cancer	0.000428	0.000818	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—thyroid cancer	0.000425	0.000812	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—thyroid cancer	0.000419	0.000801	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—thyroid cancer	0.000417	0.000796	CcSEcCtD
Metronidazole—Malaise—Epirubicin—thyroid cancer	0.000415	0.000792	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—thyroid cancer	0.000413	0.000789	CcSEcCtD
Metronidazole—Syncope—Epirubicin—thyroid cancer	0.000412	0.000787	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—thyroid cancer	0.000411	0.000786	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—thyroid cancer	0.000411	0.000786	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—thyroid cancer	0.000409	0.000781	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—thyroid cancer	0.000406	0.000776	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—thyroid cancer	0.000404	0.000772	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—thyroid cancer	0.000401	0.000766	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—thyroid cancer	0.000398	0.000761	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—thyroid cancer	0.000397	0.000758	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—thyroid cancer	0.000391	0.000747	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—thyroid cancer	0.000391	0.000747	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000389	0.000742	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—thyroid cancer	0.000384	0.000733	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—thyroid cancer	0.000383	0.000731	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—thyroid cancer	0.000382	0.00073	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—thyroid cancer	0.000381	0.000729	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—thyroid cancer	0.000381	0.000727	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—thyroid cancer	0.000378	0.000723	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—thyroid cancer	0.000376	0.000718	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—thyroid cancer	0.000375	0.000717	CcSEcCtD
Metronidazole—Oedema—Epirubicin—thyroid cancer	0.000375	0.000717	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—thyroid cancer	0.000374	0.000714	CcSEcCtD
Metronidazole—Infection—Epirubicin—thyroid cancer	0.000373	0.000712	CcSEcCtD
Metronidazole—Shock—Epirubicin—thyroid cancer	0.000369	0.000705	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—thyroid cancer	0.000369	0.000704	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—thyroid cancer	0.000368	0.000703	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—thyroid cancer	0.000367	0.000702	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—thyroid cancer	0.000367	0.000701	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—thyroid cancer	0.000364	0.000696	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—thyroid cancer	0.000363	0.000693	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—thyroid cancer	0.000362	0.000692	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—thyroid cancer	0.000362	0.000692	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00036	0.000687	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—thyroid cancer	0.000358	0.000683	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—thyroid cancer	0.000354	0.000676	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—thyroid cancer	0.00035	0.000669	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000347	0.000663	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—thyroid cancer	0.000347	0.000663	CcSEcCtD
Metronidazole—Infection—Doxorubicin—thyroid cancer	0.000345	0.000659	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000342	0.000653	CcSEcCtD
Metronidazole—Shock—Doxorubicin—thyroid cancer	0.000342	0.000652	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—thyroid cancer	0.00034	0.00065	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00034	0.000649	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—thyroid cancer	0.000339	0.000648	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—thyroid cancer	0.000337	0.000644	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—thyroid cancer	0.000337	0.000643	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000336	0.000641	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—thyroid cancer	0.000334	0.000637	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—thyroid cancer	0.000331	0.000632	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—thyroid cancer	0.00033	0.000631	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—thyroid cancer	0.000326	0.000623	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000324	0.000619	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—thyroid cancer	0.000323	0.000618	CcSEcCtD
Metronidazole—Pain—Epirubicin—thyroid cancer	0.000321	0.000613	CcSEcCtD
Metronidazole—Constipation—Epirubicin—thyroid cancer	0.000321	0.000613	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000316	0.000604	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—thyroid cancer	0.000314	0.0006	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—thyroid cancer	0.000312	0.000595	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—thyroid cancer	0.000309	0.00059	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—thyroid cancer	0.000309	0.000589	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000307	0.000586	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—thyroid cancer	0.000306	0.000584	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—thyroid cancer	0.000302	0.000576	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.0003	0.000572	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—thyroid cancer	0.000299	0.000572	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—thyroid cancer	0.000298	0.000569	CcSEcCtD
Metronidazole—Pain—Doxorubicin—thyroid cancer	0.000297	0.000567	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—thyroid cancer	0.000297	0.000567	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—thyroid cancer	0.000297	0.000566	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—thyroid cancer	0.000297	0.000566	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000286	0.000546	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000284	0.000542	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—thyroid cancer	0.000276	0.000528	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—thyroid cancer	0.000276	0.000527	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—thyroid cancer	0.000274	0.000524	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—thyroid cancer	0.000274	0.000524	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—thyroid cancer	0.000269	0.000514	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—thyroid cancer	0.000265	0.000507	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—thyroid cancer	0.000257	0.00049	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—thyroid cancer	0.000256	0.000488	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—thyroid cancer	0.000249	0.000476	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—thyroid cancer	0.000248	0.000474	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—thyroid cancer	0.000246	0.000469	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—thyroid cancer	0.000239	0.000456	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—thyroid cancer	0.000238	0.000454	CcSEcCtD
Metronidazole—Rash—Epirubicin—thyroid cancer	0.000237	0.000452	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—thyroid cancer	0.000236	0.000451	CcSEcCtD
Metronidazole—Headache—Epirubicin—thyroid cancer	0.000235	0.000449	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—thyroid cancer	0.00023	0.000438	CcSEcCtD
Metronidazole—Nausea—Epirubicin—thyroid cancer	0.000223	0.000426	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—thyroid cancer	0.000221	0.000422	CcSEcCtD
Metronidazole—Rash—Doxorubicin—thyroid cancer	0.000219	0.000418	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—thyroid cancer	0.000219	0.000418	CcSEcCtD
Metronidazole—Headache—Doxorubicin—thyroid cancer	0.000217	0.000415	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—thyroid cancer	0.000206	0.000394	CcSEcCtD
